FC ALPHA RECEPTOR BINDING ANTIBODY
    61.
    发明公开

    公开(公告)号:US20230399407A1

    公开(公告)日:2023-12-14

    申请号:US18035609

    申请日:2021-11-03

    IPC分类号: C07K16/28 C07K16/32

    摘要: The present invention relates to an antibody having enhanced binding affinity for human Fc alpha receptor and a technique for maximizing a mechanism of antibody action by using same. Antibodies specific for Fc alpha receptors or immunologically active fragments thereof according to the present invention are in the form of IgG and bind to Fc alpha receptors of effector cells, especially, neutrophils, which are most abundant in mammals, thereby overcoming the disadvantages of conventional IgA antibodies and maximizing an effector function in various antibody therapeutic agents, which leads to maximizing the mechanism of antibody action (ADCC and ADCP). Thus, various Fc-fused protein therapeutic agents using same can be advantageously utilized as antibody drugs with enhanced effector functions.